2 September 2022
ECO Animal Health Group plc (the "Company")
(AIM: EAH)
Annual Report and Accounts & Annual General Meeting
ECO Animal Health Group plc announces the publication of the following documents ("the Documents") on the Company's website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx.
· Annual Report and Accounts for the year ended 31 March 2022
· Notice of Annual General Meeting to be held at The Grange, 100 High Street, London, N14 6BN on 26 September 2022 at 11.30am ("AGM") and Form of Proxy
The Documents will be posted today to those shareholders that have elected to receive them by post.
For further information please contact:
ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)
| 020 8447 8899
|
IFC Advisory Graham Herring Zach Cohen
|
020 3934 6630
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas |
020 7496 3000 |
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi
Peel Hunt LLP (Joint Broker) Dr Christopher Golden James Steel |
020 7597 5970
020 7418 8900 |
Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.